Accelrys Up 33.6% Since SmarTrend Uptrend Call (ACCL)
Comtex SmarTrend(R) - Mon Dec 22, 5:10PM CST
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 15 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)
Accelrys Shares Up 33.6% Since SmarTrend's Buy Recommendation (ACCL)
Comtex SmarTrend(R) - Mon Dec 15, 11:06AM CST
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 15 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)
Shares of ACCL Up 33.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Dec 01, 9:20AM CST
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 15 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)
33.6% Return Seen to Date on SmarTrend Accelrys Call (ACCL)
Comtex SmarTrend(R) - Fri Nov 21, 4:48PM CST
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 14 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)
Accelrys Has Returned 33.6% Since SmarTrend Recommendation (ACCL)
Comtex SmarTrend(R) - Thu Oct 23, 5:02PM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 13 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)
Uptrend Call Working As Accelrys Stock Rises 33.6% (ACCL)
Comtex SmarTrend(R) - Wed Sep 17, 11:09AM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 12 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
ACCL: 12.51 (+0.03)
Global Bioinformatics Market Outlook 2019
M2 - Wed Sep 17, 5:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xtd5rk/global) has announced the addition of the "Global Bioinformatics Market Outlook 2019" report to their offering. The global bioinformatics market reached the mark of around US$ 3.7 Billion in 2013 with the anticipation of its growth at a CAGR of around 19% during 2015-2019 The report is an outcome of an in-depth research and comprehensive analysis of global developments and opportunities listed in the section of the bioinformatics trends. The bioinformatics market essentially is divided into 3 sections for a categorical study of the industry viz. by segment, by application and by region. By segment, the bioinformatics market is divided into data analysis and software, tools and database services, and IT Infrastructure. Accordingly, the report provides a comprehensive analysis of each of these segments coupled with the information on key software and databases popular in the industry. In the application area of the bioinformatics industry, the report covers various aspects of the global bioinformatics market, giving detailed analysis of its various applications, including genomics, proteomics, transcriptomics, cheminformatics, metabolomics and molecular phylogenetics, covering the sizes of the bioinformatics market for each of these application areas till 2019. The report also offers a geographical picture of the bioinformatics sector in four regions viz. North America, Europe, Asia-Pacific and Latin America. Additionally, through country level analysis, the report portrays the bioinformatics market in major countries like US, UK, South Korea, India etc., to understand their individual market growth and future directions. A competitive analysis in the report has been done with an assortment of all the major bioinformatics players that have been active in the research and development of bioinformatics products and services. It encloses the overview, key financials and strategic initiatives by the players. In a nutshell, the research provides all the prerequisite information for intending clients looking out to venture into this industry and facilitates them to devise strategies, while going for an investment/partnership in the global bioinformatics market. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Key Industry Trends and Drivers 4. Bioinformatics Market Outlook to 2019 5. Country Level Analysis 6. Commercialized Products and Services 7. Key Players - Biodiscovery, Inc. - Geneva Bioinformatics (Genebio) SA - Kinexus Bioinformatics Corporation - Accelrys, Inc. - Affymetrix, Inc. - Agilent Technologies, Inc. - CLC Bio A/S - Genologics Life Sciences Software, Inc - ID Business Solutions Ltd - Illumina Inc. - Life Technologies Corporation - NonLinear Dynamics Ltd. For more information visit http://www.researchandmarkets.com/research/xtd5rk/global
A: 41.13 (-0.24), ILMN: 186.22 (+2.72), AFFX: 9.80 (+0.05), ACCL: 12.51 (+0.03)
Drug Discovery Technologies - A Global Market Overview
M2 - Fri Aug 29, 5:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtdx3f/drug_discovery) has announced the addition of the "Drug Discovery Technologies - A Global Market Overview" report to their offering. The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening. Key Topics Covered: PART A: GLOBAL MARKET PERSPECTIVE 1. INTRODUCTION 2. KEY MARKET TRENDS 3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE 4. KEY GLOBAL PLAYERS 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE 1. THE UNITED STATES 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART C: GUIDE TO THE INDUSTRY 1. NORTH AMERICA 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART
A: 41.13 (-0.24), OSIR: 14.87 (+0.13), ILMN: 186.22 (+2.72), LMNX: 18.60 (+0.37), AFFX: 9.80 (+0.05), QGEN: 23.20 (+0.09), BCOR: 13.90 (-0.03), ACCL: 12.51 (+0.03), ABT: 45.70 (-0.02), INCY: 71.57 (+1.99), BMY: 59.15 (-0.01), WAT: 114.54 (+0.21), ISIS: 59.49 (+1.88), SIAL: 137.16 (-0.01), BASI: 2.09 (-0.11), MRK: 57.46 (+0.25), CGEN: 8.58 (-0.17), CRL: 63.59 (+0.33), CELGZ: 3.34 (-0.01), NVS: 93.91 (+0.66)